Clinical Trials
임상시험 트래커
국내사는 전체 임상 이력, 글로벌 메이저는 진행 중 파이프라인을 추적합니다. ClinicalTrials.gov API v2에서 6시간 주기로 수집합니다.
기업
60 results (top 60)
- 2상모집 예정· Multiple Myeloma (MM)고위험 다발성 골수종에 대한 다중 표적 면역요법(Multi-Immune HR)
MMulti-Immune HR; Multi-Target Immunotherapy for High-Risk Multiple Myeloma
협력: 얀센(J&J)
- 2상모집 예정· Penile Squamous Cell Carcinoma전이성/재발성 음경편평상피세포암종에서 아미반타마브
Amivantamab in Patients With Metastatic/Recurrent Penile Squamous Cell Carcinoma
협력: 얀센(J&J)
- 2상모집 예정· Asthma부적절하게 조절되는 중등도에서 중증 천식 환자를 대상으로 한 JNJ-95597528 연구
A Study of JNJ-95597528 in Participants With Inadequately Controlled Moderate to Severe Asthma
리드: 얀센(J&J)
- 3상모집 예정· Multiple Myeloma신규진단 다발성골수종: 라만타미그 플러스 다라투무맙 대 표준 치료
A Study of Ramantamig Plus Daratumumab Versus Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone (DVRd) or Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With NDMM For Whom Stem Cell Transplant is Not Planned
리드: 얀센(J&J)
- 단계 미표기모집 예정· Inflammatory Bowel Diseases성인 염증성장질환 환자에서 구셀쿠맙의 장기 지속성 연구
A Study of Long Term Persistency of Guselkumab in Adult Participants With Inflammatory Bowel Disease
리드: 얀센(J&J)
- 단계 미표기모집 예정· Venous Thromboembolism2세 미만 정맥혈전색전증(VTE) 소아에서 리바록사반의 사용 패턴 및 안전성 관찰 연구
A Study to Observe the Pattern of Use and Safety of Rivaroxaban in Children Under 2 Years Old With Venous Thromboembolism (VTE)
협력: 얀센(J&J)
- 4상모집 중· Psoriasis치료 목적으로 TREMFYA를 투여받는 수유 중인 여성의 모유에서 TREMFYA 농도 평가 연구
A Study to Assess Concentration of TREMFYA in Breast Milk of Lactating Women Who Are Receiving TREMFYA Therapeutically
리드: 얀센(J&J)
- 1상모집 중· Prostatic Neoplasms진행성 전립선암 환자에서 JNJ-98768111의 임상시험
A Study of JNJ-98768111 in Participants With Advanced Prostate Cancer
리드: 얀센(J&J)
- 2상모집 중· Cytokine Release Syndrome재발 또는 난치성 골수종 환자에서 테클리스타맙 또는 탈케타맙 치료 중 사이토카인 방출 증후군 예방을 위한 인플릭시맙
Infliximab for Cytokine Release Syndrome Prophylaxis During Teclistamab or Talquetamab Therapy in Patients With Relapsed or Refractory Myeloma
협력: 얀센(J&J)
- 2상모집 중· Carcinoma, Non-Small-Cell Lung절제 가능한 EGFR 변이 비소세포폐암 환자에서 신보조 아미반타맙과 라제르티닙 또는 항암화학요법의 병용 연구
A Study of Neoadjuvant Amivantamab With Either Lazertinib or Chemotherapy in Participants With Resectable EGFR-Mutated NSCLC
리드: 얀센(J&J)
- 3상모집 중· Depressive Disorder, Treatment-Resistant치료 저항성 우울증 환자에서 에스케타민 비강분무 대 위약 분무 연구
A Study of Esketamine Nasal Spray Versus Placebo Spray in Adult Participants With Treatment-resistant Depression
리드: 얀센(J&J)
- 2상모집 중· Multiple Myeloma재발/불응성 다발성 골수종의 라만타미그 투여 시 토실리주맙의 사이토카인 방출 증후군 예방 효과 평가
A Study Evaluating the Prophylactic Use of Tocilizumab to Prevent Cytokine Release Syndrome With Ramantamig Administration in Participants With Relapsed/Refractory Multiple Myeloma
리드: 얀센(J&J)
- 1상모집 중· Healthy건강한 수유 중인 여성의 모유에서 니포칼리맙 농도 평가 연구
A Study to Assess Nipocalimab Concentrations in Breast Milk of Healthy Lactating Women
리드: 얀센(J&J)
- 단계 미표기모집 중· Non-Muscle Invasive Bladder Neoplasms미국의 비근육침습성 방광암 환자에서 TAR-200의 실제 사용 및 결과 평가 연구
A Study to Assess Real-World Use and Outcomes of TAR-200 for Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) in the United States
리드: 얀센(J&J)
- 3상모집 중· Multiple Myeloma재발 또는 치료 불응성 다발성 골수종 환자에서 JNJ-79635322와 테클리스타맙을 비교하는 연구
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
리드: 얀센(J&J)
- 3상모집 중· Colitis, Ulcerative중등도에서 중증 활동성 궤양성 대장염 환자에서 JNJ-78934804에 관한 연구
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
리드: 얀센(J&J)
- 3상모집 중· Crohn Disease중등도에서 중증 활동성 크론병 환자에서 JNJ-78934804에 관한 연구
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
리드: 얀센(J&J)
- 단계 미표기모집 중· Leukemia, Lymphocytic, Chronic, B-Cell만성 림프구성 백혈병 환자에서 정해진 기간 동안 투여하는 이브루티닙과 베네토클락스(I+V) 1차 치료의 실제 임상 연구
A Real-world Study of Ibrutinib and Venetoclax (I+V) First-Line Treatment Given for Fixed-duration of Time in Participants With Chronic Lymphocytic Leukemia
리드: 얀센(J&J)
- 단계 미표기모집 중· Psoriasis루마니아의 중등도~중증 판상 건선 환자에서 구셀쿠맙 치료의 지속성 연구
A Study of Persistence to Guselkumab Treatment in Participants With Moderate-to-Severe Plaque Psoriasis in Romania
리드: 얀센(J&J)
- 1상모집 중· Hematologic Neoplasms재발 또는 불응성 혈액 악성종양에 대한 JNJ-95804306 연구
A Study of JNJ-95804306 for Relapsed or Refractory Hematological Malignancies
리드: 얀센(J&J)
- 단계 미표기모집 중· Colitis사우디아라비아에서 궤양성 대장염 및 크론병에 대한 구셀쿠맙의 실제 임상 연구
A Real-World Study of Guselkumab in Ulcerative Colitis and Crohn's Disease in Saudi Arabia
리드: 얀센(J&J)
- 3상모집 중· Depressive Disorder, MajorA Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
리드: 얀센(J&J)
- 3상모집 중· Crohn DiseaseA Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
리드: 얀센(J&J)
- 1상모집 중· Metastatic Breast CancerA Study of HLD-0117 in Patients With Metastatic Breast Cancer
리드: 얀센(J&J)
- 3상모집 중· Lupus Erythematosus, SystemicA Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
리드: 얀센(J&J)
- 1/2상모집 중· Carcinoma, Non-Small-Cell LungA Study of Amivantamab and Olomorasib Combination Therapy in Participants With Metastatic Non-Small Cell Lung Cancer
리드: 얀센(J&J)
- 2상모집 중· Multiple MyelomaA Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma
리드: 얀센(J&J)
- 2상모집 중단 (진행 중)· Dermatitis, AtopicA Study of JNJ-95597528 in Participants With Moderate to Severe Atopic Dermatitis
리드: 얀센(J&J)
- 1상모집 중· Lymphoma, Non-HodgkinA Study of JNJ-95566692 in Participants With Non-Hodgkin Lymphoid Malignancies
리드: 얀센(J&J)
- 2상모집 중· Arthritis, PsoriaticA Study to Evaluate the Efficacy and Safety of JNJ-88545223 for the Treatment of Participants With Active Psoriatic Arthritis
리드: 얀센(J&J)
- 1상모집 중· Prostatic NeoplasmsA Study of Pasritamig (JNJ-78278343) in Combination With JNJ-86974680 for Treatment of Prostate Cancer
리드: 얀센(J&J)
- 3상모집 중· Depressive Disorder, MajorA Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder
리드: 얀센(J&J)
- 3상모집 중· Myasthenia GravisComparative Efficacy of Nipocalimab and Efgartigimod in Participants With Generalized Myasthenia Gravis
리드: 얀센(J&J)
- 3상모집 중· Prostatic Neoplasms, Castration-ResistantA Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
리드: 얀센(J&J)
- 1상모집 중· Relapsed Refractory Multiple Myeloma (RRMM)Mezigdomide and Talquetamab in Relapsed and Refractory Multiple Myeloma
협력: 얀센(J&J)
- 단계 미표기모집 중· Hemolytic Disease of the Fetus and NewbornA Study on Hemolytic Disease of the Fetus and Newborn (HDFN) Through Global Registry
리드: 얀센(J&J)
- 2상모집 중· Multiple Myeloma (MM)Study for Frail Patients With Newly Diagnosed Multiple Myeloma Treated With Daratumumab With Teclistamab or Talquetamab.
협력: 얀센(J&J)
- 단계 미표기모집 중· Arthritis, PsoriaticA Study of Guselkumab in Participants With Psoriatic Arthritis (PsA) in a Real-World Setting
리드: 얀센(J&J)
- 단계 미표기모집 중· Carcinoma, Non-Small-Cell LungA Study of Clinical Outcomes in Participants With EGFR Mutated Advanced Non-Small Cell Lung Cancer (NSCLC) in a Real-World Setting
리드: 얀센(J&J)
- 3상모집 중· Squamous Cell Carcinoma of Head and NeckA Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
리드: 얀센(J&J)
- 1상모집 중· Acute Lymphoblastic LeukemiaA Study of 14C-Bleximenib (Radiolabeled) in Participants With Acute Leukemia
리드: 얀센(J&J)
- 2상모집 중· Multiple Myeloma in RelapseSubcutaneous Talquetamab in Elderly Patients With Multiple Myeloma in Early Relapse
협력: 얀센(J&J)
- 1상모집 중· Advanced-stage Solid TumorsA Study of JNJ-89862175 for Treatment of Advanced Solid Tumors
리드: 얀센(J&J)
- 2/3상모집 중· Crohn DiseaseA Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
리드: 얀센(J&J)
- 2상모집 중· Multiple MyelomaA Study to Evaluate Efficacy and Safety of Ciltacabtagene Autoleucel
리드: 얀센(J&J)
- 3상모집 중· Colitis, UlcerativeA Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
리드: 얀센(J&J)
- 3상모집 중· Non-Muscle Invasive Bladder NeoplasmsA Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer
리드: 얀센(J&J)
- 3상모집 중· Metastatic Castration-resistant Prostatic NeoplasmsA Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
리드: 얀센(J&J)
- 1상모집 중· Multiple MyelomaTalquetamab in Combination With Iberdomide and Dexamethasone for Relapsed or Refractory Multiple Myeloma
협력: 얀센(J&J)
- 1상모집 중· Advanced Stage Solid TumorsA Study of JNJ-95437446 in Participants With Advanced-Stage Solid Tumors
리드: 얀센(J&J)
- 1상모집 중· Prostatic NeoplasmsA Study of JNJ-78278343 in Combination With JNJ-95298177 for Treatment of Prostate Cancer
리드: 얀센(J&J)
- 2상모집 중단 (진행 중)· AL AmyloidosisA Phase II Trial of Teclistamab in Participants With Previously Treated Immunoglobulin Light-chain (AL) Amyloidosis
협력: 얀센(J&J)
- 3상모집 중· Leukemia, Myeloid, AcuteA Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
리드: 얀센(J&J)
- 1/2상모집 중· Metastatic Castrate-Resistant Prostate Cancer (mCRPC)Investigating SX-682 in Combination With Apalutamide in Metastatic Castration-resistant Prostate Cancer
협력: 얀센(J&J)
- 3상모집 중단 (진행 중)· Plaque PsoriasisA Study to Assess Efficacy and Safety of JNJ-77242113 Compared to Placebo and Ustekinumab in Participants With Moderate to Severe Plaque Psoriasis
리드: 얀센(J&J)
- 1상모집 중· Leukemia, Myeloid, AcuteA Study of JNJ-90189892 for Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Neoplasms
리드: 얀센(J&J)
- 해당없음모집 중· Cardiovascular DiseasesBEhavioral and Adherence Model for Improving Quality, Health Outcomes and Cost-Effectiveness of healthcaRe
협력: 얀센(J&J), 노보노디스크, 화이자, 다케다
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.